Sanofi报告收入丰厚,尽管主要投资者减少了股息和股票下跌。 Sanofi reports strong earnings, despite major investors reducing stakes and a stock downgrade.

一些主要投资者调整了在一家保健公司Sanofi的股份,并减少了Raleigh资本管理和全球信托资产管理的费用。 Several major investors have adjusted their stakes in Sanofi, a healthcare company, with reductions from Raleigh Capital Management and Global Trust Asset Management. 尽管SnockNews.com将股票降为“持股”评级, Sanofi仍报告强劲收益为每股1.57美元, Despite a stock downgrade by StockNews.com to a "hold" rating, Sanofi reported strong earnings of $1.57 per share, beating analyst expectations by $1.35, and a 12.3% revenue increase to $13.44 billion. 股票保持“机动购买”共识评级,目标价格为57.50美元。 The stock maintains a "Moderate Buy" consensus rating with a $57.50 target price.